Late last year, the World Health Organization (WHO) released a preliminary report, declaring cannabidiol aka CBD to be safe for medical use. Cannabidiol is the non psychoactive cannabinoid present in cannabis. Since it does not get you baked, CBD is used entirely for medical purposes. Since CBD use has become common, the cannabinoid has shown great promise in treating a wide variety of different medical conditions, including different types of epilepsy.
Inside the WHO’s Report
From the report:
There is increased interest from Member States in the use of cannabis for medical indications including for palliative care. Responding to that interest and increase in use, WHO has in recent years gathered more robust scientific evidence on therapeutic use and side effects of cannabis and cannabis components.
One of the main arguments, ne excuses given for keeping cannabis illegal is that there is not enough evidence that it’s safe or effective. The most prominent health organization in the world seems to think that there is.
The report goes on to say:
Recent evidence from animal and human studies shows that its use could have some therapeutic value for seizures due to epilepsy and related conditions. Current evidence also shows that cannabidiol is not likely to be abused or create dependence as for other cannabinoids (such as Tetra Hydro Cannabinol (THC), for instance).
Schedule I is reserved for substances that have a high potential for abuse. If there is no potential for abuse of CBD, then why is it scheduled?
The WHO seems to think there is no reason for it to be scheduled:
The ECDD therefore concluded that current information does not justify scheduling of cannabidiol and postponed a fuller review of cannabidiol preparations to May 2018, when the committee will undertake a comprehensive review of cannabis and cannabis related substances.
Will the DEA Listen?
There is mounting evidence showing that CBD is safe and effective for medical use. Despite this, the DEA still insists that CBD should remain a schedule I drug. Never mind the fact that CBD oil has helped countless people. The more evidence comes out in favor of CBD, the less objective the DEA and the Justice Department look.
Source: Ars Technica
Image Source: WTHR NBC News
Will the WHO’s report sway the DEA towards descheduling CBD? Tell us in the comments below!